Navigation Links
Major research collaboration will improve British athletes' performance on world stage
Date:10/27/2009

lite sport, we know that medals are won and lost within the tiniest margins. Our job at UK Sport is to ensure our athletes reach the start line knowing they are the best prepared and best equipped in the world.

"We are delighted to be working with leading experts on this exciting project, which we hope will not only benefit British athletes in the build up to our home Olympic and Paralympic Games in 2012, but also revolutionise our approach to, and application of, science, medicine and engineering in sport for years to come."


'/>"/>

Contact: Colin Smith
cd.smith@imperial.ac.uk
44-207-594-6712
Imperial College London
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Evosys, a Major Player in the Oracle E-Business Suite Implementation, Support and Consultancy Services Domain, has Recently Been Awarded Oracles Certified Advantage Partner Status
2. Virginia Restaurants Urged to Go Completely Smoke-Free After Major Report Finds Smoke-Free Laws Prevent Heart Attacks
3. Consecos Four Major Offices Wrap Up Record-Breaking United Way Campaign
4. KEAP1 Keeps major cancer-promoting protein at bay
5. Major health care challenges persist for D.C. children despite high rates of health insurance coverage, RAND study finds
6. Immune Deficiency Foundation Among the First Rare Disease Patient Organizations to Launch Major Social Networking Initiatives
7. NIH recognizes engineering professors innovative research with major award
8. Major Central Florida Label Printer Creates On-Line Label Superstore Catering To Users Of Blank Labels For Thermal Printers
9. No major role for fish in the prevention of heart failure
10. Research Reveals How Mitochondrial Gene Defects Impair Respiration, Other Major Life Functions
11. HTH Worldwide Introduces Trip Protection Insurance With Major Medical Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 26, 2014 Top 10 Best SEO ... the world. The site has recently compared many hosting ... HostMonster are among the most reliable Linux web hosting ... Top 10 Best SEO Hosting says, “The hosting suppliers ... companies who outperform their competitors on hosting features, uptime ...
(Date:10/25/2014)... Triton Algae Innovations, ... Dr. Xun Wang has joined the firm as ... Triton has developed a patented synthetic biology platform for ... Dr. Wang, the platform uses algae to produce novel ... “Algae are unique because they can produce compounds that ...
(Date:10/25/2014)... New York (PRWEB) October 25, 2014 ... http://www.thexareltolawsuit.com/ ) will be addressed in December, when the ... next hearing session. According to a Hearing Session Order ... on the matter will be heard on December 4, ... begin at 9:30 a.m. (In Re: Xarelto Products Liability ...
(Date:10/25/2014)... (HealthDay News) -- Arriving home safe and sound is one ... end, be sure that costumes and goody bags have reflective ... an emergency medicine doctor at Meadowlands Hospital Medical Center in ... and costumes should be flame-resistant, Davis said. He offers ... makeup, test it on a small area of skin first ...
(Date:10/25/2014)... 2014 Background: , In 1998 Bob ... is a pioneer in the field of establishing recovery community ... treatment system and when he retired, he set out to ... public service. , 1. Where are the ... them? , 2. Can the recovery community be organized ...
Breaking Medicine News(10 mins):Health News:Top 10 Best SEO Hosting Announces That GreenGeeks.com And HostMonster Are Among The Most Reliable Linux Web Hosting Companies In 2014 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Tips for Safe Trick-or-Treating 2Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2
... is unfair in dealing with people suffering from cancer. Patients ... pay higher premiums even when they can prove they are ... found that 90 percent of cancer sufferers were being denied ... cancer patients, but anyone with a pre-existing condition is treated ...
... mushrooms along with a variety of other vegetables could ... damage// , the common pathway for cancer, ageing and ... researcher, measured antioxidant capacity in several kinds of mushrooms, ... of which is called the crimini mushroom, or, when ...
... will soon become the first province in Canada to ... of heart failure//. ,The provincial agency in ... in guidelines that allowed accepting donation after cardio-circulatory death ... hundreds. ,This move to permit donations after ...
... rate of transplant surgeries, doctors are rethinking on the ... Committee (AHEC) is deliberating //over the permission for medical ... and on the ventilator, with a motive to remove ... addresses the issue of removal of organs from the ...
... scorpion venom protein showed possibilities of treating brain ... Cambridge have developed a radioactive version of a ... named TM-601, as a safer and different way ... ,Responding to this urgent problem, scientists at ...
... in London created a lot of commotion which led to the ... curable disease and is characterized by cough, phlegm, weight loss, fatigue ... many years. Elizabeth Garrett Anderson and Obstetric Hospital sent letters to ... Hospital. ,Though the health worker was diagnosed to have ...
Cached Medicine News:Health News:Ontario Addresses Shortage of Transplant Organs 2Health News:Brain Cancer Could be Safely Treated with Radioactive Scorpion Venom 2
(Date:10/22/2014)...  Quest Diagnostics (NYSE: DGX ), the ... that its Board of Directors has elected Jeffrey M. ... 1, 2014. Including Dr. Leiden, the Board has 11 ... and CEO of Vertex Pharmaceuticals.   Dr. Leiden has ... in the pharmaceutical and biotechnology industries as well as ...
(Date:10/22/2014)... RPh, of Vernak Farms Pharmacy in Skaneateles, ... Roentsch Scholarship by the Professional Compounding Centers of America ... during PCCA,s International Seminar, held October 8-10, ... pharmacist and PCCA member who embodies the innovative and ... pharmacist in the compounding community. George ...
(Date:10/22/2014)... VERNE, Calif. , Oct. 22, 2014 /PRNewswire/ ... readiness products, has developed APLS ® Body ... that minimizes the spread of bacteria and virus ... APLS Body Guard Bio features a rugged, ... finished edges that create a leak-proof inner chamber ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2
... , , , ... ) today announced that in a large, randomized, double-blind, placebo-controlled, Phase ... dialysis), anemia and type-2 diabetes (the T rial to ... T herapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) ...
... , , RIDGEFIELD, Conn., Aug. ... of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran)(1) study will ... in Barcelona on Sunday, Aug. 30. The primary objective ... the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the ...
Cached Medicine Technology:Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 2Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 3Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 6Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 7Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 8Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 2Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 3Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 4Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 5Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 6Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 7